Physician profile
David J Kearney
NPI 1023009347
$886.96
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $157 · 2021: $111 · 2022: $305 · 2023: $83.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $129.38 | 2019-2022 | |
| Blue Earth Diagnostics | $107.96 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $106.27 | 2021-2023 | Prolaris |
| Janssen Biotech, INC. | $52.67 | 2019-2022 | |
| Antares Pharma, INC. | $44.49 | 2022 | |
| Abbvie INC. | $39.26 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $38.02 | 2019 | |
| Merck Sharp & Dohme LLC | $37.67 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $36.64 | 2019-2022 | |
| Coloplast Corp | $33.80 | 2021-2022 | |
| Cook Medical LLC | $32.95 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $31.98 | 2019-2020 | |
| Teleflex LLC | $25.16 | 2022 | |
| Urogen Pharma, INC. | $25.09 | 2022 | |
| Axonics, INC. | $22.44 | 2023 | Axonics |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $21.04 | 2023 | Orgovyx |
| Sun Pharmaceutical Industries INC. | $18.71 | 2023 | Yonsa |
| Baudax Bio INC. | $17.62 | 2022 | |
| Convatec INC. | $16.97 | 2021 | |
| Urovant Sciences INC | $16.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.54 | 2019 | |
| Alnylam Pharmaceuticals INC. | $14.34 | 2022 | |
| Travere Therapeutics, INC. | $2.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kearney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.